MedinCell S.A. Announced earnings results for the half year ended September 30, 2020. For the half year, the company announced total revenue was EUR 3.146 million compared to EUR 3.909 million a year ago. Operating loss was EUR 8.151 million compared to EUR 8.092 million a year ago. Net loss was EUR 10.754 million compared to EUR 8.999 million a year ago. Basic loss per share from continuing operations was EUR 0.51 compared to EUR 0.45 a year ago.